ArticleOncotarget2015

A novel cancer immunotherapy based on the combination of a synthetic carbohydrate-pulsed dendritic cell vaccine and glycoengineered cancer cells.

Lei Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.